DNTH EPS Estimates
Dianthus Therapeutics, Inc.
$75.37
+$0.61(+0.82%)
43
Overall
60
Value
27
Tech
44
Quality
Market Cap
$4.18B
Volume
5.11K
52W Range
$32.22 - $117.88
Target Price
$140.13
DNTH EPS estimates: the consensus estimate for Dianthus Therapeutics, Inc.'s current fiscal year is -$3.81 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
DNTH EPS Estimates
- EPS estimate, current quarter
- $-1.01
- EPS estimate, next quarter
- $-1.06
- EPS estimate, current year
- $-3.81
- EPS estimate, next year
- $-4.74
- EPS growth, 3-year
- +41.18%
| Fiscal year | EPS |
|---|---|
| 2025 | $-4.20 |
| 2024 | $-2.55 |
| 2023 | $-8.45 |
| 2022 | $-20.64 |
| 2021 | $-20.64 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DNTH | $75.37 | +0.8% | 5.11K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Dianthus Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW